NeuroBo Pharmaceuticals, Inc. - Common Stock (NQ:NRBO)

2.360 UNCHANGED

Last Price Updated: 3:59 PM EST, Nov 27, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NeuroBo Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing

December 03, 2024

Via ACCESSWIRE

Life Sciences Investor Forum: Presentations Now Available for Online Viewing

November 15, 2024

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Life Sciences Investor Forum Agenda Announced for November 14th

November 12, 2024

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

NeuroBo Pharmaceuticals to Present at the November 21st Virtual Investor Summit Microcap Event

November 11, 2024

Via ACCESSWIRE

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 16, 2024

Via Benzinga

NRBO Stock Earnings: NeuroBo Pharmaceuticals Misses EPS for Q2 2024 ↗

August 14, 2024

NRBO stock results show that NeuroBo Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

NeuroBo Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying ↗

June 26, 2024

Via Benzinga

NeuroBo Pharmaceuticals Stock Slides Despite Animal Study Showing Wegvoy, Liver Fibrosis Success ↗

May 22, 2024

NeuroBo says DA-1241 data shows improved liver fibrosis and additive hepatoprotective effects when combined with semaglutide.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 22, 2024

Via Benzinga

NRBO Stock Earnings: NeuroBo Pharmaceuticals Misses EPS for Q1 2024 ↗

May 09, 2024

NRBO stock results show that NeuroBo Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 29, 2024

Via Benzinga

The Top 3 Stocks to Watch This Week ↗

February 05, 2024

There are three stocks to watch this week as they experienced significant price movements worth your attention.

Via InvestorPlace

Dow Jumps 250 Points; Honeywell Issues Weak Forecast ↗

February 01, 2024

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 250 points on Thursday. The Dow traded up 0.66% to 38,403.91 while the NASDAQ rose 1.01% to 15,316.80. The...

Via Benzinga

Topics Stocks

Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 01, 2024

Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 01, 2024

Via Benzinga

Stocks Rise Amid Flood Of Economic Data ↗

February 01, 2024

Stocks are comfortably higher this afternoon, as investors continue to unpack the Fed's rate decision as well as this morning's jobs data.

Via Talk Markets

Topics Economy

Crude Oil Gains 1%; ISM Manufacturing PMI Tops Expectations ↗

February 01, 2024

U.S. stocks traded higher midway through trading, with the S&P 500 gaining around 0.5% on Thursday. The Dow traded up 0.23% to 38,238.99 while the NASDAQ rose 0.54% to 15,245.46. The S&P 500 also rose,...

Via Benzinga

Topics Stocks

NeuroBo Pharmaceuticals Inc. (NASDAQ: NRBO) is One of Thursday Morning’s Most Active Stocks

February 01, 2024

Via Investor Brand Network

Why Obesity-Drug Maker NeuroBo Stock Is Trading Higher ↗

February 01, 2024

NeuroBo announced that the FDA has cleared its IND application for DA-1726, a novel, dual oxyntomodulin (OXM) analog agonist that functions as a glucagon-like peptide-1 receptor (GLP1R) and glucagon...

Via Benzinga

Nasdaq Surges 100 Points; US Jobless Claims Increase To 224,000 ↗

February 01, 2024

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.14% to 38,204.88 while the NASDAQ...

Via Benzinga

Topics Stocks

What's Going On With Clinical-Stage Biotech Firm NeuroBo Shares Today? ↗

December 29, 2023

NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares are trading lower in Friday's premarket session after ending Thursday's session with a whopping 21.2% gain.

Via Benzinga

Life Science Investor Forum: Presentations Now Available for Online Viewing

December 15, 2023

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Life Science Investor Forum Agenda Announced for December 14th, 2023

December 12, 2023

From Virtual Investor Conferences

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 31, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 18, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 24, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 28, 2023

Via Benzinga

Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

June 28, 2023

Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market.

Via Benzinga

NeuroBo Pharma Says Its Weight Loss Candidate Outperforms Major Competitors in Preclinical Obesity Study ↗

June 27, 2023

NeuroBo Pharmaceuticals Inc (NASDAQ: NRBO) says its DA-1726, a novel oxyntomodulin analog functioning as a glucagon-like peptide-1 receptor and glucagon receptor dual agonist, had been shown to elicit...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

June 05, 2023

Monday's session saw 41 companies set new 52-week lows.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.